HG-7-85-01 是一种Bcr-Abl,PDGFRα,Kit和Src激酶的野生型和看门突变形式的 II 型 ATP 竞争性抑制剂。HG-7-85-01 抑制 T315I 突变型Bcr-Abl(T315I mutantBcr-Abl) 激酶,KDR和RET,IC50为 3 nM,20 nM 和 30 nM,对其他激酶的抑制作用很小或没有抑制作用 (IC50>2 μM)。HG-7-85-01 通过诱导细胞凋亡 (apoptosis) 和抑制细胞周期进程来抑制细胞增殖。
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
3-{2-[(cyclopropylcarbonyl)amino][1,3]thiazolo[5,4-b]pyridin-5-yl}-N-{4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide
CAS number:1258391-13-7 molecular formula:C31H31F3N6O2S
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | - | ||
| CAS number | 1258391-13-7 | molecular formula | C31H31F3N6O2S |
| molecular weight | 608.7 g/mol | Exact mass | ≥99% |
| PSA | 119.000 Ų | logp | 5.000 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





